Healthy Living BEYOND Weight Study
1 other identifier
observational
1,000,000
1 country
1
Brief Summary
The Healthy Living BEYOND Weight Study is an observational research study of participants living with overweight and obesity. The principal objectives for this project will be to answer fundamental unanswered questions regarding patient experiences and outcomes related to overweight and obesity, and to assess the real-world effectiveness of different weight management strategies, within contemporary and diverse populations. To accomplish this, the Study Team for this project will leverage their expertise in the science of obesity and cardiometabolic health; epidemiology, cohort and registry studies; implementation science; cardiovascular prevention and management; and disparities and community-based research to lead the development of an innovative cohort of people living with overweight or obesity with two key components:
- 1.patient-report data elements, obtained through surveys;
- 2.linkage to EHR records providing data regarding clinical encounters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2025
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 3, 2025
CompletedStudy Start
First participant enrolled
June 30, 2025
CompletedFirst Posted
Study publicly available on registry
July 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2060
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2060
August 6, 2025
August 1, 2025
35.4 years
June 3, 2025
August 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Answer fundamental unanswered questions regarding patient experiences and outcomes related to overweight and obesity.
From enrollment to at least 10 years post enrollment, continuous follow up
Evaluate the real-world effectiveness of different weight management strategies, within contemporary and diverse patient populations.
From enrollment to at least 10 years post enrollment, continuous follow up
Create a community of volunteers interested in advancing research on the conditions of overweight/obesity and related weight management strategies.
From enrollment to at least 10 years post enrollment
To provide an enduring resource of value to individuals living with overweight and obesity.
From enrollment to at least 10 years post enrollment
Study Arms (1)
Direct-to-Participant Group
Observational
Interventions
Eligibility Criteria
Individuals currently residing in the United States
You may qualify if:
- BMI at the time of enrollment of 25 kg/m2 or greater or other elevated adiposity measures (e.g., waist circumference of greater than 102cm (40 in) in men or 88cm (35 in) in women) OR adults with a BMI less than 25 due to previous or current weight management treatment (lifestyle, pharmacological or surgical).
You may not qualify if:
- Incarcerated at the time of enrollment
- Self-reported pregnancy at the time of enrollment. However, individuals who become pregnant after enrollment will be welcomed to continue to participate, given that the critical life period of pregnancy often has a significant impact on subsequent weight trajectories.
- Terminal illness or end-stage disease with a life expectancy of less than 6-months
- Employed by the American Heart Association or working on the Healthy Living BEYOND Weight Study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- American Heart Associationlead
- Evidation Healthcollaborator
- Duke Clinical Research Institutecollaborator
- Johns Hopkins Universitycollaborator
Study Sites (1)
American Heart Association
Dallas, Texas, 75231, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 3, 2025
First Posted
July 20, 2025
Study Start
June 30, 2025
Primary Completion (Estimated)
December 1, 2060
Study Completion (Estimated)
December 1, 2060
Last Updated
August 6, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- July 2026 - ending 5 years after study close
- Access Criteria
- Study participant de-identified data will be accessible by the AHA and organizations doing work on their behalf such as qualified researchers, academic institutions, patient-advocacy groups, pharmaceutical, medical device companies, Evidation Health, Inc., and more. Study participant de-identified data may be used for the following: * Determination of clinical Study eligibility and subsequent screening, recruitment and enrollment. If a participant chooses to join a clinical Study for which they are eligible, they may be asked to sign an additional Study-specific consent form. * Use for research across a variety of disciplines and for use in scientific publications, interventional and/or product development. Data will be stored in a HIPAA-compliant, secure electronic platform with access limited to authorized study personnel and authorized researchers with executed data use agreements.
Data from surveys will be combined with data from the EHR. Data that are stored in the integrated study database will use unique participant identification numbers, with data otherwise de-identified. We will utilize multiple data quality control processes to ensure the accuracy and reliability of study data. The integrated database will be maintained by the AHA or another service provider that is approved in advance by the IRB. Data collected as part of the Healthy Living BEYOND Weight Study will be used for research purposes only and will not be used for diagnosis or disease management.